---
title: "Shuttle Pharmaceuticals Holdings, Inc. (SHPH.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/SHPH.US.md"
symbol: "SHPH.US"
name: "Shuttle Pharmaceuticals Holdings, Inc."
industry: "Biotechnology"
---

# Shuttle Pharmaceuticals Holdings, Inc. (SHPH.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.shuttlepharma.com](https://www.shuttlepharma.com) |

## Company Profile

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candida...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.34 | 123/605 | - | - | - |
| PB | 2.59 | 206/605 | 2.54 | 1.28 | 0.55 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/SHPH.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/SHPH.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/SHPH.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.